A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 100/50 Inhalation Powder/GSK in Healthy Volunteers

Condition:   Bioequivalence Interventions:   Drug: Test Product;   Drug: Reference Product Sponsors:   Respirent Pharmaceuticals Co Ltd.;   BECRO Ltd. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials